Health
Promising Results from Merck and Moderna's Melanoma Vaccine Trials
By Editor • August 19, 2026 • 1 min read
Merck and Moderna report promising trial results for their melanoma vaccine, intismeran autogene, in combination with Keytruda.
Read more